CSIMarket
 


Metacrine Inc   (MTCR)
Other Ticker:  
 
 

MTCR's EPS from Cont. Operations Growth by Quarter and Year

Metacrine Inc 's EPS from Cont. Operations results by quarter and year




MTCR EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.45 0.42 0.00
III Quarter September -0.13 -0.69 -1.41 0.00
II Quarter June -0.15 -0.59 0.00 0.00
I Quarter March -0.31 -0.57 0.00 0.00
FY   -0.59 -2.30 -0.99 0.00



MTCR EPS from Cont. Operations third quarter 2022 Y/Y Growth Comment
Metacrine Inc in the third quarter 2022 recorded EPS loss from Cont. Operations of $ -0.13 .

According to the results reported in the third quarter 2022, Metacrine Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Metacrine Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




MTCR EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Metacrine Inc 's third quarter 2022 EPS from Cont. Operations $ -0.13 MTCR's Income Statement
Metacrine Inc 's third quarter 2021 EPS from Cont. Operations $ -0.69 Quarterly MTCR's Income Statement
New: More MTCR's historic EPS from Cont. Operations Growth >>


MTCR EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Metacrine Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MTCR's III. Quarter Q/Q EPS from Cont. Operations Comment
Despite the fact, that Metacrine Inc in the III. Quarter 2022 revealed EPS loss from Cont. Operations of $ -0.13 , management point out, that current results show improvement relative to the -0.15 in the second quarter.

Within Major Pharmaceutical Preparations industry Metacrine Inc achieved highest sequential EPS from Cont. Operations growth. While Metacrine Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MTCR's III. Quarter Q/Q EPS from Cont. Operations Comment
Even if Metacrine Inc in the III. Quarter 2022 showed EPS loss from Cont. Operations of $ -0.13 , some analyst said, that those numbers are improvement compare to the -0.15 in the second quarter.

Within Major Pharmaceutical Preparations industry Metacrine Inc achieved highest sequential EPS from Cont. Operations growth. While Metacrine Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Metacrine Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -1.04 $ -1.60 $ -2.04 $ -2.30 $ -1.43
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Metacrine Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Metacrine Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
MTCR's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for MTCR's Competitors
EPS from Cont. Operations Growth for Metacrine Inc 's Suppliers
EPS from Cont. Operations Growth for MTCR's Customers

You may also want to know
MTCR's Annual Growth Rates MTCR's Profitability Ratios MTCR's Asset Turnover Ratio MTCR's Dividend Growth
MTCR's Roe MTCR's Valuation Ratios MTCR's Financial Strength Ratios MTCR's Dividend Payout Ratio
MTCR's Roa MTCR's Inventory Turnover Ratio MTCR's Growth Rates MTCR's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2022
Addus Homecare Corporation-1.35%$ -1.351 
Zoetis Inc -2.59%$ -2.586 
Ironwood Pharmaceuticals inc -2.94%$ -2.941 
Universal Health Services Inc -4.91%$ -4.906 
Henry Schein Inc-5.17%$ -5.172 
Pediatrix Medical Group Inc -5.41%$ -5.405 
Charles River Laboratories International inc -7.32%$ -7.317 
Synaptogenix Inc -8.51%$ -8.511 
Semler Scientific Inc -9.84%$ -9.836 
Sotera Health Company-10.00%$ -10.000 
National Research Corporation-10.53%$ -10.526 
Intuitive Surgical Inc -14.95%$ -14.953 
Meridian Bioscience Inc -15.08%$ -15.080 
Retractable Technologies inc -15.79%$ -15.789 
Lemaitre Vascular Inc -16.67%$ -16.667 
Molecular Templates inc -18.52%$ -18.519 
Regeneron Pharmaceuticals Inc -19.91%$ -19.909 
Docgo Inc -25.00%$ -25.000 
Maravai Lifesciences Holdings Inc -26.09%$ -26.087 
Progyny Inc -26.32%$ -26.316 
Zynex inc -27.78%$ -27.778 
Merck and Co Inc -29.28%$ -29.282 
Organon and Co -29.92%$ -29.921 
Abbott Laboratories-30.51%$ -30.508 
Gilead Sciences Inc -30.58%$ -30.583 
West Pharmaceutical Services Inc -31.65%$ -31.646 
Alpha Pro Tech Ltd -33.33%$ -33.333 
Laboratory Corporation Of America Holdings-35.90%$ -35.902 
Lhc Group Inc -35.96%$ -35.955 
Encompass Health Corporation-36.63%$ -36.634 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com